551. Use of Aerosolized Antibiotics in Gram-Negative Ventilator-Associated Pneumonia in Trauma Patients.
- Author
-
Gibson BH, Sharpe JP, Lewis RH, Newell JS, Swanson JM, Wood GC, Fabian TC, Croce MA, and Magnotti LJ
- Subjects
- Acinetobacter baumannii isolation & purification, Administration, Inhalation, Adolescent, Adult, Aerosols administration & dosage, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Pneumonia, Bacterial complications, Pneumonia, Bacterial microbiology, Pneumonia, Ventilator-Associated complications, Pneumonia, Ventilator-Associated microbiology, Pseudomonas aeruginosa isolation & purification, Young Adult, Anti-Bacterial Agents administration & dosage, Gram-Negative Aerobic Rods and Cocci isolation & purification, Pneumonia, Bacterial drug therapy, Pneumonia, Ventilator-Associated drug therapy, Wounds and Injuries complications
- Abstract
Ventilator-associated pneumonia (VAP) is associated with significant morbidity (ventilator days, ICU days, and cost) and mortality increase in trauma patients. Multidrug-resistant strains of causative VAP pathogens are becoming increasingly common. Aerosolized antibiotics achieve high alveolar concentrations and provide valuable adjuncts in the treatment of VAP. This study examined the impact of aerosolized antibiotics in the treatment of VAP in trauma patients. Patients with either Acinetobacter baumannii or Pseudomonas aeruginosa VAP over 10 years treated with aerosolized antibiotics (cases) were stratified by age, severity of shock, and injury severity. A frequency-matched (by causative pathogen) control group treated without aerosolized antibiotics was used for comparison. Multivariable logistic regression was used to identify predictors for the use of aerosolized antibiotics. One hundred twenty VAP episodes were identified in 100 patients. Microbiologic resolution was achieved in all patients treated with aerosolized antibiotics. There was no difference in mortality (14.5% vs 15.7%, P = 0.87) and no antibiotic-related complications in either group. Multivariable logistic regression identified VAP persistence and relapse as independent predictors for the use of aerosolized antibiotics. Combined with systemic therapy, aerosolized antibiotics broaden the spectrum of therapy. They are valuable adjuncts with minimal risk of antibiotic resistance and/or systemic complications.
- Published
- 2018